Risks and benefits of long-term bisphosphonate therapy-Reference-Cited by-同舟云学术

Risks and benefits of long-term bisphosphonate therapy

Published:2010-06-15 Issue:12 Volume:67 Page:994-1001
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Schmidt Ginelle A.¹,Horner Kathleen E.²,McDanel Deanna L.³,Ross Mary B.⁴,Moores Kevin G.⁵

Affiliation:

1. College of Pharmacy and Health Sciences, Drake University, Des Moines, IA

2. University of Iowa Hospitals and Clinics (UIHC), Iowa City, and Assistant Professor (Clinical), College of Pharmacy, University of Iowa (UI), Iowa City

3. UIHC, and Assistant Professor (Clinical), College of Pharmacy, UI

4. Department of Pharmaceutical Care, UIHC, and Adjunct Associate Professor, College of Pharmacy, UI

5. Division of Drug Information Service, College of Pharmacy, UI

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/67/12/994/28344194/ajhp0994.pdf

Reference50 articles.

1. Effects of risedronate treatment on vertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial;Harris;JAMA,1999

2. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in post-menopausal women with low bone mass: results of the FOSIT study;Pols;Osteoporos Int,1999

3. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial;Black;J Clin Endocrinol Metab,2000

4. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians;Qaseem;Ann Intern Med,2008

5. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis;Liberman;N Engl J Med,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term consequences of osteoporosis therapy with bisphosphonates;Archives of Endocrinology and Metabolism;2023-11-13

2. MOFs and bone: Application of MOFs in bone tissue engineering and bone diseases;Chinese Chemical Letters;2023-07

3. Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?;International Journal of Molecular Sciences;2021-08-19

4. Recent advances in bone-targeting nanoparticles for biomedical applications;Materials Chemistry Frontiers;2021

5. Lycopene as an antioxidant in the prevention and treatment of postmenopausal osteoporosis;Aging;2020